Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort vs Pulmicort in Chinese COPD patients
NCT00421122Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Sep 2006; status: completed.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00421122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00421122.